Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Respiratory Inhalers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
- Report Code : TIPRE00003093
- Pages : 254
The respiratory inhalers market is expected to reach US$ 43,446.2 million by 2028 from US$ 31,144.6 million in 2022; it is estimated to grow at a CAGR of 5.7% from 2022 to 2028.
The rising cases of respiratory disorders and growing adoption of generic inhalers are among the key forces bolstering the market. However, high lack of early diagnosis and high cost of inhalers hinders the respiratory inhalers market growth.
Inhalers for respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma are medical devices which deliver medicine to prevent, control and treat symptoms and help reduce exacerbations. The medicine inside the inhaler goes directly into the airways when the patient breathe in.
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other respiratory diseases is increasing across the globe. For example, according to the World Health Organization (WHO), in 2022, the number of asthma-related deaths in 2019 was 455,000. In addition, the Burden of Disease Study in 2019 recorded 212.3 million cases of COPD worldwide, resulting in 3.3 million deaths. According to the March of Dimes Organization, there were between 70,000 and 100,000 cases of cystic fibrosis across the globe in 2019. In addition, one of the major causes of respiratory diseases such as COPD and asthma is the rise in air pollution. The Organization for Economic Co-operation and Development (OECD) estimates that global emissions of greenhouse gases are likely to increase by ~50% by 2050, mainly due to a 70% increase in CO2 emissions. In addition, it is estimated that the atmospheric concentration of greenhouse gases could reach 685 parts per million (ppm) CO2 equivalent by 2050, which would cause average temperatures to rise 3–6ºC above pre-industrial levels. In addition, the beneficial effects on patients through combination therapy for asthma have increased, which has increased the demand for respiratory inhalers market such as dry powder inhalers and soft-mist inhalers, as they are one of the best ways to administer combination drugs. Hence, the increasing prevalence of respiratory diseases among the growing population is one of the factors driving the respiratory inhalers market growth.
Product Type Insights
The respiratory inhalers market, by product type, is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder segment held the largest market share in 2021, however metered dose inhalers is anticipated to register the highest CAGR of 6.3% during the forecast period (2022–2028). Metered dose inhalers (MDIs) are handheld pressurized inhalation systems that deliver small, precisely measured therapeutic doses of medication directly to the airways of a patient. They are handheld pressurized inhalation systems that deliver small, precisely measured therapeutic doses of medication directly to the airways of a patient. MDI devices include a valve and actuator designed to facilitate a consistent delivery of a specific dose of a drug to the patient in particles of a specific size distribution delivered via a propellant. MDIs require gas propellants with vapor pressures that allow them to be liquefied at ambient temperatures at pressures between 40 and 70 psi inside the canister. Propellants used in MDIs for inhaled medications must be certified by the FDA as current Good Manufacturing Practice (cGMP) inhalation grade with high purity levels. Propellants for MDIs must meet cGMP requirements for the methods, facilities, and controls used in manufacturing, processing, and packaging to ensure the product is safe for use and that it has the ingredients and strength it claims to have (FDA 2020a). The first HFC MDI approved by the FDA was for albuterol sulfate utilizing HFC-134a propellant in 1996. As of 2020, the number of FDA-approved MDI products has reached 13 and is expected to expand considerably.
The metered dose inhalers are further classified into pressured metered dose inhalers and connected metered dose inhalers. The pressured metered dose inhaler (pMDI) has been a mainstay in the treatment of respiratory diseases, especially asthma since its introduction in 1956. It is the most commonly prescribed delivery system for administering inhaled bronchodilators and antiinflammatory agents worldwide. Spacer devices, when used properly, substantially improve the delivery of pMDI-generated aerosols to the distal airways. The pMDI, used alone or in combination with a spacer or valved-holding chamber, is the most convenient and cost-effective way to administer aerosolized medications for most patients. A pMDI contains drug, which usually is either crystallized or in solution, along with the propellant and a surfactant. Connected metered dose inhalers is a type of MDI in which a device is connected to the manual inhaler so that it becomes a digitally operated MDI. For instance, Aptar Pharma has launched HeroTracker Sense, a digital respiratory health solution that turns a standard metered dose inhaler (pMDI) into a smart connected healthcare device. HeroTracker Sense is a metered-dose inhaler (MDI) add-on connected device, designed to address patient inhalation technique and adherence. By attaching to the canister of an MDI, HeroTracker Sense has several features to help asthma and COPD patients take their medication in a more informed way. The sensors in the device enable the creation and supply of information such as co-ordination of inspiration with actuation, flow rate and inhalation duration.
Technology Insights
Based on technology, the respiratory inhalers market is divided into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held the largest market share in 2021 and it is expected to grow at the highest CAGR of 6.0% during the forecast period. Manually operated inhalers deliver short bursts of medicine quickly and easily via a portable and handheld device. The user simply removes the cap, shakes the inhaler for approximately 5 seconds, places the mouthpiece of the inhaler in their mouth, and presses the pump to release the missed dose of medication while breathing in slowly and deeply. Manual inhalers require some practice to administer medicine properly, which may be difficult for small children or elderly patients with respiratory illnesses.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Respiratory Inhalers Market – by Product Type
1.3.2 Global Respiratory Inhalers Market – by Technology
1.3.3 Global Respiratory Inhalers Market – by Disease Indication
1.3.4 Global Respiratory Inhalers Market – by Geography
2. Respiratory Inhalers Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Respiratory Inhalers Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Respiratory Inhalers Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. Respiratory Inhalers Market – Global Analysis
6.1 Global Respiratory Inhalers Market Revenue Forecast and Analysis
6.2 Global Respiratory Inhalers Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type
7.1 Overview
7.2 Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology
8.1 Overview
8.2 Global Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication
9.1 Overview
9.2 Global Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. Respiratory Inhalers Market – Revenue and Forecast to 2028 – Geographic Analysis
10.1 North America: Respiratory Inhalers Market
10.1.1 Overview
10.1.2 North America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.3.2 North America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.3.3 North America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.4 North America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.5 North America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.6 North America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.7 US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.8 US: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.8.1 US: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.8.2 US: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.8.3 US: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.9 US: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10 US: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.10.1 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.1.1 Overview
10.1.10.1.2 Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.1.3 Canada: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.10.1.3.1 Canada: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.10.1.3.2 Canada: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.10.1.3.3 Canada: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.10.1.4 Canada: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10.1.5 Canada: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.10.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.2.1 Overview
10.1.10.2.2 Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.10.2.3 Mexico: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.10.2.3.1 Mexico: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.10.2.3.2 Mexico: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.1.10.2.3.3 Mexico: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.10.2.4 Mexico: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.10.2.5 Mexico: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.2 Europe: Respiratory Inhalers Market
10.2.1 Overview
10.2.2 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.3 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.3.1 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.3.2 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.3.3 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.4 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.5 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6 Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
10.2.6.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.1 Overview
10.2.6.1.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.1.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.1.3.1 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.1.3.2 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.1.3.3 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.1.4 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.1.5 UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.1 Overview
10.2.6.2.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.2.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.2.3.1 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.2.3.2 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.2.3.3 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.2.4 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.2.5 Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.1 Overview
10.2.6.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.3.3.1 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.3.3.2 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.3.3.3 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.3.4 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.3.5 France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.1 Overview
10.2.6.4.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.4.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.4.3.1 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.4.3.2 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.4.3.3 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.4.4 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.4.5 Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.1 Overview
10.2.6.5.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.5.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.5.3.1 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.5.3.2 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.5.3.3 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.5.4 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.5.5 Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.2.6.6 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
10.2.6.6.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)
10.2.6.6.3.1 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)
10.2.6.6.3.2 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)
10.2.6.6.3.3 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)
10.2.6.6.4 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)
10.2.6.6.5 Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)
10.3 Asia Pacific: Respiratory Inhalers Market
10.3.1 Overview
10.3.2 Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.3.1 Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.3.2 Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.3.3 Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.1.3.1 China: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.1.3.2 China: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.1.3.3 China: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.1.4 China: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.1.5 China Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.2.3.1 Japan: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.2.3.2 Japan: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.2.3.3 Japan: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.3 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.3.3.1 India: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.3.3.2 India: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.3.3.3 India: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.3.4 India: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.3.5 India: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.4 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 Australia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.4.3.1 Australia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.4.3.2 Australia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.4.3.3 Australia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.4.4 Australia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.4.5 Australia: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.5 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 South Korea: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.5.3.1 South Korea: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.5.3.2 South Korea: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.5.3.3 South Korea: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.5.4 South Korea: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.5.5 South Korea: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.3.6.6.3.2 Rest of Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.3.6.6.3.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4 Middle East & Africa Respiratory Inhalers Market
10.4.1 Overview
10.4.2 Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.3.1 Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.3.2 Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.3.3 Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.5 Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6 Middle East & Africa: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.1.3.1 Saudi Arabia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.1.3.2 Saudi Arabia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.1.3.3 Saudi Arabia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.1.4 Saudi Arabia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.1.5 Saudi Arabia Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 South Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.2.3.1 South Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.2.3.2 South Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.2.3.3 South Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.2.4 South Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.2.5 South Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.3 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 UAE: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.3.3.1 UAE: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.3.3.2 UAE: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.3.3.3 UAE: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.3.4 UAE: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.3.5 UAE Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.4.6.4.3.1 Rest of Middle East & Africa: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.4.6.4.3.2 Rest of Middle East & Africa: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.4.6.4.3.3 Rest of Middle East & Africa: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5 South & Central America Respiratory Inhalers Market
10.5.1 Overview
10.5.2 South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.3.1 South & Central America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.3.2 South & Central America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.3.3 South & Central America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.4 South & Central America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.5 South & Central America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6 South & Central America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.1.3.1 Brazil: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.1.3.2 Brazil: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.1.3.3 Brazil: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.1.5 Brazil: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.2.3.1 Argentina: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.2.3.2 Argentina: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.2.3.3 Argentina: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.2.5 Argentina: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.5.6.3 Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.5.6.3.3.1 Rest of South & Central America: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.5.6.3.3.2 Rest of South & Central America: Respiratory Inhalers Market, by Metered Dose Inhalers, 2019–2028 (US$ Million)
10.5.6.3.3.3 Rest of South & Central America: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Respiratory Inhalers Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Global Respiratory Inhalers Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Respiratory Inhalers Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 AstraZeneca Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Beximco Pharmaceuticals Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Boehringer Ingelheim International GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Cipla Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 GSK Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 OMRON Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PARI Respiratory Equipment, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Teva Pharmaceutical Industries Ltd
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OPKO Health, Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. US Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. US Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 12. US Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 27. Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 28. Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. UK Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 43. France Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. France Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 45. France Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 46. France Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 47. France Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 48. France Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 49. Italy Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Italy Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 51. Italy Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 55. Spain Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Spain Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 57. Spain Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 58. Spain Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 59. Spain Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 60. Spain Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. Rest of Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 63. Rest of Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 67. Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 69. Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 70. Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 71. Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 72. Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 73. China Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. China Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 75. China Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 76. China Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 77. China Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 78. China Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 79. Japan Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Japan Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 81. Japan Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 82. Japan Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 83. Japan Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 84. Japan Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 85. India Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 86. India Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 87. India Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 88. India Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 89. India Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 90. India Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 91. Australia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 92. Australia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 93. Australia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 94. Australia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 95. Australia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 96. Australia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 97. South Korea Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 98. South Korea Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 99. South Korea Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 100. South Korea Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 101. South Korea Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 102. South Korea Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 109. Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 110. Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 111. Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 112. Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 113. Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 114. Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 115. Saudi Arabia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 116. Saudi Arabia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 117. Saudi Arabia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 118. Saudi Arabia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 119. Saudi Arabia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 120. Saudi Arabia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 121. South Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 122. South Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 123. South Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 124. South Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 125. South Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 126. South Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 127. UAE Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 128. UAE Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 129. UAE Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 130. UAE Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 131. UAE Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 132. UAE Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 133. Rest of Middle East & Africa Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of Middle East & Africa Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 135. Rest of Middle East & Africa Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest of Middle East & Africa Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 137. Rest of Middle East & Africa Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 138. Rest of Middle East & Africa Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 139. South & Central America Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 140. South & Central America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 141. South & Central America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 142. South & Central America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 143. South & Central America Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 144. South & Central America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 145. Brazil Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 146. Brazil Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 147. Brazil Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 148. Brazil Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 149. Brazil Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 150. Brazil Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 151. Argentina Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 152. Argentina Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 153. Argentina Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 154. Argentina Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 155. Argentina Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 156. Argentina Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 157. Rest of South & Central America Respiratory Inhalers Market, by Product Type– Revenue and Forecast to 2028 (US$ Million)
Table 158. Rest of South & Central America Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 159. Rest of South & Central America Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)
Table 160. Rest of South & Central America Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 161. Rest of South & Central America Respiratory Inhalers Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 162. Rest of South & Central America Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 163. Recent Inorganic Growth Strategies in the Respiratory Inhalers Market
Table 164. Recent Organic Growth Strategies in the Respiratory Inhalers Market
Table 165. Glossary of Terms
LIST OF FIGURES
Figure 1. Respiratory Inhalers Market Segmentation
Figure 2. Respiratory Inhalers Market, by Region
Figure 3. Global Respiratory Inhalers Market Overview
Figure 4. Dry Powder Inhalers Segment Held Largest Share of Product Type Segment in Respiratory Inhalers Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Respiratory Inhalers Market, by Geography (US$ Million)
Figure 7. Global Respiratory Inhalers Market – Leading Country Markets (US$ Million)
Figure 8. Global Respiratory Inhalers Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Respiratory Inhalers Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Respiratory Inhalers Market, by Geography – Forecast and Analysis (2021–2028)
Figure 18. Market Positioning of Key Players in Respiratory Inhalers Market
Figure 19. Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 20. Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Global Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 31. Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Global Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 34. Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 39. North America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. US: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe Respiratory Inhalers Market Revenue overview, by Country, 2021 (US$ MN)
Figure 44. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)
Figure 46. UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50. Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 51. Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 52. Asia Pacific: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 53. Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Middle East & Africa: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 61. Middle East & Africa Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Saudi Arabia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. UAE: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Middle East & Africa: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South & Central America: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 67. South & Central America Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South & Central America: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
Figure 69. Brazil: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Argentina: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of South & Central America: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Impact of COVID-19 Pandemic on North American Country Markets
Figure 73. Impact of COVID-19 Pandemic on Respiratory Inhalers Market in European Countries
Figure 74. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 75. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 76. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 77. Growth Strategies in the Respiratory Inhalers Market
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the respiratory inhalers market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global respiratory inhalers market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
The List of Companies – Respiratory Inhalers Market
• AstraZeneca Plc
• Beximco Pharmaceuticals Ltd.
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• GSK Plc
• Koninklijke Philips NV
• OMRON Corp
• PARI Respiratory Equipment, Inc.
• Teva Pharmaceutical Industries Ltd.
• OPKO Health, Inc.
According to our latest study on “Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Technology, and Disease Indication,” the market is expected to grow from US$ 31,144.56 million in 2022 to US$ 43,446.19 million by 2028; it is estimated to record a CAGR of 5.7% from 2022 to 2028. The rising cases of respiratory disorders and growing adoption of generic inhalers are contributing to the overall respiratory inhalers market growth. Additionally, increasing product development activities is likely to emerge as a significant trend in the respiratory inhalers market during the forecast period. However, lack of early diagnosis and high cost of inhalers are a few factors hampering the respiratory inhalers market growth.
Increasing Product Development Activities to Boost Respiratory Inhalers Market Growth During Forecast Period
With new medical knowledge and effective medicines, treatment with a wide range of asthma inhalers continues to advance. Rising use of ventilator combination therapies and increasing investments by major players in developing sophisticated ventilator inhalers are boosting the demand for respiratory inhalers. In addition to the numerous advantages of the device such as portability, convenience, and effectiveness, the growing number of product approvals and developments is expected to strengthen the demand for respiratory inhalers in the coming years. A few of the major developments and approvals are listed below:
• In November 2022, AstraZeneca partnered with Avillion to develop PT027, an asthma rescue inhaler. PT027 is a pressurized metered-dose inhaler that delivers a fixed dose of two combined asthma medications: albuterol—a short-acting beta2-agonist and budesonide, an anti-inflammatory inhaled corticosteroid.
• In December 2020, OMRON launched WheezeScan, the world’s first wheeze detection device to help children with asthma, which is a crucial breakthrough in the field of pediatric asthma management. WheezeScan helps parents of young children detect wheezing—a clear indicator of an upcoming asthma attack-—and act accordingly.
• In December 2020, AireHealth, an innovative digital health company, received 510(k) clearance for its connected nebulizer. The device is a portable, electronic vibrating mesh nebulizer designed to nebulize liquid medications for inhalation by a patient in and out of the home and will be marketed under the brand name VitalMed.
• In October 2020, Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd., declared the product availability of Aermony RespiClick in Canada. The inhaler is indicated for the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and older and is offered in a simple-to-use inhaler.
• In September 2020, Teva Respiratory, LLC., a US affiliate of Teva Pharmaceutical Industries Ltd., announced the launch of AirDuo Digihaler inhalation powder and ArmonAir Digihaler inhalation powder, two digital maintenance inhalers for patients with asthma.
• In September 2020, GlaxoSmithKline plc and Innoviva, Inc. received FDA approval for Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US.
• In July 2020, Novartis received the European Commission (EC) approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside treatment of uncontrolled asthma in the EU.
• In May 2020, Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, received FDA clearance to introduce its connected platform to AstraZeneca’s Symbicort. The platform helps digitize the treatment of asthma and chronic obstructive pulmonary disease (COPD)
• In January 2020, FDA approved the CapMedic smart inhaler cap from Cognita Labs, which is capable of transmitting signals to patients to use inhalers correctly.
Thus, such increasing advancements by various market players and product approvals are likely to catalyze the growth of the global respiratory inhalers market during the forecast period.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd.; GSK Plc; Koninklijke Philips NV; OMRON Corp; PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc. are among the leading companies operating in the respiratory inhalers market.
The report segments the respiratory inhalers market as follows:
The respiratory inhalers market is segmented on the basis of product type, technology, disease indication, and geography. Based on product type, the respiratory inhalers market is segmented nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment is further bifurcated into multi-dose dry powder inhalers and single-dose dry powder inhalers. The metered dose inhalers (MDI) segment is further divided into pressured metered dose inhalers and connected metered dose inhalers. The nebulizers segment is subsegmented into compressed air nebulizers, mesh air nebulizers, and ultrasonic air nebulizers. Based on technology, the respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. Based on disease indication, the respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. Based on geography, the respiratory inhalers market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, Thailand, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Related Reports
- $3,000.00 – $5,000.00
